Una situacin que podra comenzar a aliviarse a partir del 1 de julio, fecha a partir de la cual Espaa contar con un nuevo medicamento para el mismo fin, el Mounjaro , que se sumar a Ozempic, Rybelsus, Trulicity, Victoza, Saxenda y Wegovy
The new Department of Health and Human Services secretary, Robert F
These include: Nausea the most frequently reported adverse effect, particularly during dose escalation Vomiting Diarrhoea Constipation Decreased appetite (which, whilst therapeutically intended, can occasionally be excessive) Abdominal discomfort or pain These effects are generally dose-dependent and tend to be most pronounced during the initial weeks of treatment or when the dose is increased
If constipation persists, ask your clinician about safe OTC options
While this can be transformative for overall health and confidence, rapid weight loss usually leads to unintended consequences in both the face and body